5-alpha reductase inhibitors use in prostatic disease and beyond.
Journal Information
Full Title: Transl Androl Urol
Abbreviation: Transl Androl Urol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Urology & Nephrology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-22-690/coif). EC serves as an unpaid editorial board member of Translational Andrology and Urology from August 2022 to July 2024. MLP reports that he has received the Australiasian Fulbright Commission Scholarship through the Kinghorn Foundation. The other authors have no conflicts of interest to declare."
"Funding: None."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025